12 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
comparison between SGLT ... -2 inhibitors - ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes ... cardiovascular #renal #SGLT2i
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... Metformin + SGLT2 ... ) Dpp4 + SGLT2 ... Combination #Tablets #Oral ... Pharmacology #Pills #Endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... SGLT2 (sodium/glucose ... • Euglycemic diabetic ... EricsMedicalLectures/featured #SGLT2 ... #endocrinology
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... nephron; unlike SGLT1 ... transport protein 2 (SGLT2 ... SGLT2 inhibitors ... there are three SGLT2
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... Medications • SGLT2i ... (Dapagliflozin) ... sarahthelyon #Diabetes ... pathophysiology #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... EricsMedicalLectures/featured #diabetes ... comparison #management #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... class of anti-diabetic ... /ambcarerx #SGLT2 ... #Endocrinology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... in Diabetes Management ... CARB ABSORPTION INHIBITOR ... Prandase) • SGLT ... @AmyChung #Oral
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... Ketoacidosis (EuDKA) SGLT2 ... Inhibitors Increasing ... #Euglycemic #Diabetic ... diagnosis #management #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP-4 inhibitor ... receptor agonist, SGLT2i ... α-glucosidase inhibitor ... comparison #table #endocrinology